Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 10/24/11 → 10/24/17 |
Funding
- Astellas Pharma US, Inc (2689-CL-0005)
Prot# 2689-CL-0005: A Phase 1 Study of AC220 (ASP2689) in Combination with Induction and Consolidation Chemotherapy in Patients with Newly Diagnosed Acute Myeloid Leukemia
- Altman, Jessica K (PD/PI)
Project: Research project